Raquel E. Reinbolt

1.6k total citations
56 papers, 1.1k citations indexed

About

Raquel E. Reinbolt is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Raquel E. Reinbolt has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Raquel E. Reinbolt's work include Cancer survivorship and care (14 papers), Cancer-related cognitive impairment studies (13 papers) and Cancer Treatment and Pharmacology (9 papers). Raquel E. Reinbolt is often cited by papers focused on Cancer survivorship and care (14 papers), Cancer-related cognitive impairment studies (13 papers) and Cancer Treatment and Pharmacology (9 papers). Raquel E. Reinbolt collaborates with scholars based in United States, Israel and Switzerland. Raquel E. Reinbolt's co-authors include Maryam B. Lustberg, Charles L. Shapiro, John L. Hays, Robert Wesolowski, Bhuvaneswari Ramaswamy, Patrick White, Rudolph M. Navari, Nicole Williams, Anne M. Noonan and Jeffrey VanDeusen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Raquel E. Reinbolt

54 papers receiving 1.1k citations

Peers

Raquel E. Reinbolt

ONCOL

PRM

PHEOH

PPCH

Janise M. Roh United States

Pauline A. J. Vissers Netherlands

Akira Tsunoda Japan

Qin Xu China

Ahmet Alacacıoğlu Türkiye

Peter T. Silberstein United States

Melissa Accordino United States

Murat Akyol Türkiye

Mehmet Artaç Türkiye

Hee Jun Kim South Korea

Janise M. Roh United States

Raquel E. Reinbolt

720 ×1.2

ONCOL

145 ×0.7

PRM

168 ×1.3

146 ×1.1

PHEOH

138 ×1.3

PPCH

Citations per year, relative to Raquel E. Reinbolt Raquel E. Reinbolt (= 1×) peers Janise M. Roh

Countries citing papers authored by Raquel E. Reinbolt

Since Specialization

Citations

This map shows the geographic impact of Raquel E. Reinbolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raquel E. Reinbolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raquel E. Reinbolt more than expected).

Fields of papers citing papers by Raquel E. Reinbolt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raquel E. Reinbolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raquel E. Reinbolt. The network helps show where Raquel E. Reinbolt may publish in the future.

Co-authorship network of co-authors of Raquel E. Reinbolt

This figure shows the co-authorship network connecting the top 25 collaborators of Raquel E. Reinbolt. A scholar is included among the top collaborators of Raquel E. Reinbolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raquel E. Reinbolt. Raquel E. Reinbolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madison, Annelise A., Rebecca Andridge, Megan E. Renna, et al.. (2023). Inflamed but not impulsive: Acute inflammatory cytokine response does not impact prepotent response inhibition. Journal of Affective Disorders. 342. 1–9. 3 indexed citations

Renna, Megan E., Annelise A. Madison, Juan Peng, et al.. (2023). Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial. PubMed Central. 1 indexed citations

Madison, Annelise A., Megan E. Renna, Rebecca Andridge, et al.. (2023). Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases. Pain. 164(9). 1985–1994. 5 indexed citations

Bischof, Jason J., et al.. (2023). Diagnosis of cancer in the Emergency Department: A scoping review. Cancer Medicine. 12(7). 8710–8728. 25 indexed citations

Renna, Megan E., M. Rosie Shrout, Annelise A. Madison, et al.. (2022). Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer Trajectory. International Journal of Behavioral Medicine. 30(4). 463–472. 6 indexed citations

Nyrop, Kirsten A., Allison M. Deal, Stephanie B. Wheeler, et al.. (2021). Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Research and Treatment. 191(2). 409–422. 15 indexed citations

Nyrop, Kirsten A., Allison M. Deal, Bryce B. Reeve, et al.. (2020). Patient‐reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer. 127(6). 957–967. 9 indexed citations

Shachar, Shlomit Strulov, Allison M. Deal, Katherine E. Reeder‐Hayes, et al.. (2020). Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a. JNCI Cancer Spectrum. 4(6). pkaa082–pkaa082. 21 indexed citations

Sardesai, Sagar, Mohamed Badawi, Ewa Mrózek, et al.. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Investigational New Drugs. 38(5). 1400–1410. 24 indexed citations

10.

Madison, Annelise A., Alex Woody, Maryam B. Lustberg, et al.. (2020). Cognitive problems of breast cancer survivors on proton pump inhibitors. Journal of Cancer Survivorship. 14(2). 226–234. 3 indexed citations

11.

Stover, Daniel G., Robert Wesolowski, Sagar Sardesai, et al.. (2020). Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study. World Journal of Surgical Oncology. 18(1). 11–11. 18 indexed citations

12.

Bonsu, Janice M., Avirup Guha, Vedat Yildiz, et al.. (2020). Reporting of Cardiovascular Events in Clinical Trials Supporting FDA Approval of Contemporary Cancer Therapies. Journal of the American College of Cardiology. 75(6). 620–628. 48 indexed citations

13.

Nyrop, Kirsten A., Allison M. Deal, Shlomit Strulov Shachar, et al.. (2019). Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice. Cancer. 125(17). 2945–2954. 65 indexed citations

14.

Berger, Michael, Craig Vargo, Junan Li, et al.. (2019). Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience. Journal of Oncology Pharmacy Practice. 26(3). 572–579. 4 indexed citations

15.

Padin, Avelina C., Stephanie J. Wilson, William B. Malarkey, et al.. (2019). Physical Activity After Breast Cancer Surgery: Does Depression Make Exercise Feel More Effortful than It Actually Is?. International Journal of Behavioral Medicine. 26(3). 237–246. 14 indexed citations

16.

Milks, M. Wesley, Nishaki Mehta, Vedat Yildiz, et al.. (2018). Usefulness of Integrating Heart Failure Risk Factors Into Impairment of Global Longitudinal Strain to Predict Anthracycline-Related Cardiac Dysfunction. The American Journal of Cardiology. 121(7). 867–873. 17 indexed citations

17.

Lustberg, Maryam B., et al.. (2015). Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Molecular and Cellular Endocrinology. 402. 51–56. 10 indexed citations

18.

Reinbolt, Raquel E., Roshan M. Patel, Xueliang Pan, et al.. (2015). Risk factors for anthracycline-associated cardiotoxicity. Supportive Care in Cancer. 24(5). 2173–2180. 39 indexed citations

19.

Layman, Rachel M., Amy S. Ruppert, Ewa Mrózek, et al.. (2013). Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer. Cancer Chemotherapy and Pharmacology. 71(5). 1183–1190. 31 indexed citations

20.

Reinbolt, Raquel E., et al.. (2011). Pneumocystis jiroveci Pneumonia in an Atypical Host. Clinical Breast Cancer. 12(2). 138–141. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact